Robert Stewart, MD
Pulmonary Disease · Tupelo, MSNPI 1932165073
Payments from drug & device makers
Across 561 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$2K
- Boehringer Ingelheim$1K
- Jazz Pharmaceuticals Inc.$602
- Mallinckrodt Hospital Products Inc.$449
- Insmed, Inc.$364
- plus $4K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 74 | $1,934 |
| GSK | 129 | $1,573 |
| Boehringer Ingelheim | 82 | $1,339 |
| Jazz Pharmaceuticals Inc. | 28 | $602 |
| Mallinckrodt Hospital Products Inc. | 25 | $449 |
| Insmed, Inc. | 16 | $364 |
| Sanofi | 17 | $321 |
| Harmony Biosciences LLC | 15 | $320 |
| Regeneron Healthcare Solutions, Inc. | 14 | $309 |
| Merck | 16 | $302 |
| Genentech USA, Inc. | 24 | $287 |
| Fisher & Paykel Healthcare Inc | 2 | $217 |
| Electromed, Inc. | 12 | $214 |
| Actelion Pharmaceuticals US, Inc. | 11 | $197 |
| United Therapeutics Corporation | 8 | $165 |
| Astellas Pharma US Inc | 5 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $133 |
| Novartis | 8 | $130 |
| Baxter Healthcare | 3 | $116 |
| Amgen | 7 | $115 |
| Sunovion Pharmaceuticals Inc. | 10 | $93 |
| Bayer | 6 | $91 |
| Verona Pharma, Inc. | 4 | $83 |
| Grifols USA, LLC | 3 | $82 |
| Mylan Specialty L.p. | 5 | $81 |
| Viatris Specialty LLC | 3 | $67 |
| Mallinckrodt Enterprises LLC | 4 | $66 |
| Pulmonx Corporation | 3 | $65 |
| Portola Pharmaceuticals, LLC | 3 | $58 |
| Gilead | 4 | $54 |
| Tetraphase Pharmaceuticals, Inc. | 3 | $54 |
| Medtronic | 1 | $44 |
| La Jolla Pharmaceutical Company | 3 | $42 |
| Pfizer | 2 | $34 |
| Aerin Medical Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $14 |
| Monaghan Medical Corporation | 1 | $12 |
| Ceribell, Inc. | 1 | $6 |
How this compares
$10,194 in reported general payments places this provider in the 65th percentile of 101 pulmonary disease providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Tupelo
- Jaime UngoTupelo$29K
- William EdmonsonTupelo$15K
- Paul PerryTupelo$13K
- Kevin HarbourTupelo$13K
- David WittyTupelo$7K
- Ryan SessumsTupelo$4K
- Jose Henao CorreaTupelo$4K
- William FrazierCanton$809K
- Demondes HaynesJackson$809K
- Bobby TullosGulfport$361K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.